Using Prognostic Nutritional Index and Systemic Immune-Inflammation Index to Evaluate Short-Term Survival in Hospitalized Octogenarian and Nonagenarian Patients
PDF
Cite
Share
Request
Original Research
E-PUB
7 July 2025

Using Prognostic Nutritional Index and Systemic Immune-Inflammation Index to Evaluate Short-Term Survival in Hospitalized Octogenarian and Nonagenarian Patients

Eur J Geriatric Gerontol. Published online 7 July 2025.
1. İstanbul Medeniyet University Faculty of Medicine Department of Urology, İstanbul, Türkiye
No information available.
No information available
Received Date: 02.03.2025
Accepted Date: 21.04.2025
E-Pub Date: 07.07.2025
PDF
Cite
Share
Request

Abstract

Objective

This study aimed to investigate the associations between the preoperative Prognostic Nutritional Index (PNI), Systemic Immune-Inflammation Index (SII), and short-term survival in octogenarian and nonagenarian patients who were admitted to the urology department.

Materials and Methods

We evaluated 136 octogenarian and nonagenarian patients who were admitted to the urology department. The patient-related data were collected, including demographic and comorbidities. Surgical treatment patterns and outcomes were assessed. Patients’ SII and PNI scores were calculated. PNI was calculated as total lymphocyte count (109/L) × 5 + albumin concentration (g/L). SII was calculated as neutrophil count (109/L) × platelet count (109/L)/lymphocyte count (109/L). The cut-off values of PNI and SII were determined through receiver operating characteristic analysis. Overall survival (OS) was estimated by Kaplan-Meier analysis. The log-rank test was used to compare differences between the groups. Univariate and multivariate COX regression analyses were performed to assess the predictive values of PNI and SII for OS.

Results

The study population comprised 105 women (77.2%) and 31 men (22.8%), with a median age of 84 years (range, 80-97 years). The most common reason for hospitalization was hematuria, affecting 47 patients (34.6%). A total of 74 patients (54.4%) underwent surgical intervention. The optimal cut-off values for predicting OS were identified as 1243, 42.65, and 32.37 for SII, PNI, and SII/PNI, respectively. Kaplan-Meier analysis also revealed that low PNI was related to poorer OS in octogenarian and nonagenarian patients.

Conclusion

Preoperative PNI and SII, based on standard laboratory measurements, may be useful noninvasive, inexpensive, and simple tools for predicting short-term survival of octogenarian and nonagenarian patients admitted to the urology department.

Keywords:
Octogenarian, nonagenarian, Prognostic Nutritional Index, Systemic Immune-Inflammation Index

Introduction

Currently, life expectancy is increasing and aging populations are growing remarkably. It is thought that life expectancy will increase with each passing year. It is projected that the demographic cohort of individuals aged 80 years and above will expand to exceed 150 million (1). Additionally, this ageing population needs more healthcare services, compared to the younger population. In patients aged over 80, urological diseases occur more frequently, leading to longer hospital stays and higher complication rates compared to younger patients (2). Therefore, it is necessary to adopt a specialized approach when dealing with patients over 80 years of age.

The Prognostic Nutritional Index (PNI) evaluates immune function and overall nutritional health; it is a clinical tool that measures nutritional status in several diseases, such as hepatocellular carcinoma and colorectal cancer (3). The Systemic Immune-Inflammation Index (SII) plays a pivotal role in carcinogenesis and serves as a robust prognostic indicator for various solid neoplasms, including esophageal squamous cell carcinoma, germ cell tumors, and hepatocellular carcinoma (4-6).

Octogenarian and nonagenarian nutritional status and hospitalization are important for life expectancy and overall survival (OS). To our knowledge, no studies have specifically examined the prognostic value of SII and PNI in this population. Our study aims to evaluate the prognostic effect of the SII and PNI in relation to short-term survival among elderly patients aged 80 and above.

Materials and Methods

A retrospective study was conducted on 136 octogenarian and nonagenarian patients who were hospitalized in the urology department of a single center between January 2021 and September 2023, after receiving approval from University of Health Sciences Türkiye Medeniyet University Göztepe Training and Research Hospital’s Ethics Committee (decision number: 2023/0823, date: 29.11.2023). The patient data set comprised a range of variables, including demographics, comorbidities, diagnoses that led to the patients being hospitalized, the procedures that were performed, the American Society of Anesthesiologists scores of the patients who underwent surgery, the Dindo et al. (7) classification was employed for the assessment of complications, the length of hospital stay, the usage of antiplatelet/anticoagulant therapy, the patients’ smoking status, the Katz Index of Independence in activities of daily living, and the WHOQOL-OLD score.

Upon admission to the clinic, the patient’s PNI and SII were calculated according to the following methodology:

• The PNI is calculated as follows: PNI = [(10 × albumin (g/dL)] + (0.005 × Lymphocyte count)

• SII is calculated as follows: platelet count × NLR (neutrophil count/lymphocyte count)

Statistical Analysis

The statistical analysis were conducted using the IBM SPSS Statistics software, version 22. Normally distributed continuous variables are reported as the mean with standard deviation, and non-normally distributed continuous variables are reported as the median with range. T-tests were applied to normally distributed variables, and Mann-Whitney U tests were used for non-normally distributed variables. The optimal cut-off values of the PNI and SII were found by ROC curve analysis. We utilized the Kaplan-Meier method to estimate the probability of survival. The independent predictors of survival were determined through a multivariate COX regression model. The independent predictors of PNI and SII were determined using univariate and multivariate logistic regression. Calculations were performed to derive hazard ratios (HR) and 95% confidence intervals (CIs), where a p-value of less than 0.05 was considered statistically significant.

Results

Patient Characteristics and Clinical Outcomes

Of the 136 individuals in the study, 77.2% were women (n=105) and 22.8% were men (n=31) (Table 1). Most of these patients (56.6%) were smokers. The most common reason for hospitalization was hematuria, affecting 47 patients (34.6%). The other reasons for hospitalization are postrenal acute kidney injury (AKI) (18.4%), urolithiasis (5.9%), and malignancy (14.7%).  A total of 74 patients (54.4%) underwent surgical intervention. The most frequently performed surgical procedure was transurethral resection of bladder tumor, accounting for 59.5% of cases. A total of 25 patients (18.4%) were hospitalized due to post-renal AKI. Percutaneous nephrostomy was performed in 14 patients (10.3%), while Double-J stent was inserted in four patients (2.9%).  The intervention was not performed on 5 patients (5.2%).

Patient Demographics, Characteristics and Their Associations with PNI

The association between pre-admission PNI levels and patient demographics and clinical factors is shown in Table 2. Patients with lower PNI (<42.65) were significantly more likely to be older, have lower body mass index (BMI), (p=0.002), higher Electrocorticography Performance Status (p=0.002), AKI during hospitalization (p=0.001), elective admission (p=0.001), and longer hospital stays (p=0.001). A significant association was found between pre-hospitalization age (p=0.009) and reason for hospitalization (p=0.033), but not between pre-hospitalization age (p=0.009) and gender (p=0.793).

Patient Demographics, Characteristics and Their Associations with SII

The demographic and clinical attributes of the patients, as they relate to their pre-hospital SII, are shown in Table 3. Patients with higher SII exhibited higher PNI (p=0.001). SII was significantly associated with length of hospital stay (p=0.030) but not with age (p=0.871) or gender (p=0.793).

Optimal Cut-off Points for SII, PNI, and the SII/PNI Ratio

Using ROC curve analysis, we defined the optimal cut-off values for the SII, PNI, and the combined SII/PNI index. The optimal cut-off values for predicting OS were identified as 1243 for SII, 42.65 for PNI, and 32.37 for SII/PNI, respectively. The area under the curve for OS was 0.699, 0.723, and 0.728 for SII, PNI, and SII/PNI, respectively (Figure 1). Percutaneous nephrostomy tubes were placed in patients who had dilated upper systems. Although this improves the short-term survival of these patients, who have a percutaneous nephrostomy tube associated with poorer OS (p<0.001) (Figures 2A), it does not affect long-term outcomes. On the other hand, no statistically significant difference in OS was observed between male and female patients (p=0.684) (Figure 2B).

Factors Affecting Patient Survival: A Univariate and Multivariate Analysis

The univariate analysis showed that OS was significantly influenced by ECOG-PS, percutaneous nephrostomy procedures, reasons for hospitalization, SII, PNI, Katz Index scores, and hospital stay length.

Multivariate COX regression analysis revealed that percutaneous nephrostomy (HR 5.013, 95% CI 2.485-10.114, p<0.001), PNI (HR 0.926, 95% CI 0.890-0.964, p<0.001), and length of hospital stay (HR 1.040, 95% CI 1.002-1.079, p=0.038) were independent predictors of OS, as shown in Table 4.

Discussion

The aging population and extended life expectancy have contributed to considerable growth in the number of geriatric patients requiring urological treatment. In the absence of evidence-based guidelines specific to the management of frail elderly patients, case studies can offer valuable insights into the complex diagnostic and therapeutic dilemmas encountered in this population (8). In recent times, there has been a notable increase in interest surrounding the prognostic value of SII and PNI. Additionally, emerging research highlights the role of inflammation in disease initiation, progression, and metastasis, as well as its impact on immune regulation (9-12). The study’s aim is to examine the clinical utility and predictive power of SII and PNI in hospitalized individuals aged 80 and above, and to analyze their comparative predictive accuracy. Our study results indicates that a high SII and low PNI prior to surgery are independent predictors of short-term survival in patients over the age of 80.

On the other hand, patient-related factors, including systemic inflammatory response (SIR) markers, can also influence cancer progression and prognosis. Malnutrition, indicated by low albumin levels, is linked to increased morbidity, mortality, and impaired response to cancer treatment. It also weakens the immune system, promoting tumor recurrence (13-17). In our study, we found that the low PNI group patients’ survival was less than the other group. The mechanisms of SIR are complex and remain controversial.  Neutrophils have been linked to the presence of chemokines, growth factors and proteases that regulate angiogenesis. This could potentially influence the tumor’s blood supply and growth rate (18-21). It was observed that cancer patients with a SII greater than 330×109 cells/L exhibited a poorer prognosis compared to those with lower SII scores (22). Elevated SII levels, characterized by increased granulocyte and platelet counts and decreased lymphocyte counts, suggest a weakened immune response and heightened inflammatory state, leading to adverse outcomes. Neutrophils are integral components of innate immunity, playing a crucial role in host defense mechanisms such as antibody-dependent cellular cytotoxicity and phagocytosis (23). The present study revealed that elevated SII was associated with lower BMI, fewer double-J stents, more percutaneous nephrostomy tubes, longer hospital stays, and increased emergency hospitalizations.

A reduction in the number of lymphocytes in the bloodstream may be indicative of an impaired anti-tumor immune response. Additionally, it is established that the inflammatory response associated with the tumor and the cytokines released because of this inflammation can lead to a reduction in blood albumin levels, which may, in turn, contribute to tumor progression (24-25).

The PNI was initially proposed as a means of assessing the immunological and nutritional status of patients who have undergone gastrointestinal surgery (26). It is also known that the lymphocyte count and the blood albumin level have prognostic importance (27).  Lymphocytes, another essential component of the PNI, play a pivotal role in cell-mediated immune responses, which can significantly impact tumor recurrence and progression. Additionally, a compromised nutritional status can further contribute to tumor progression by hindering tumor immunity. This immunosuppressed state can lead to suboptimal outcomes in cancer patients. PNI has been shown to be a valuable prognostic marker in various cancers. Systemic inflammation has been linked to tumor progression, recurrence, metastasis, and poor oncological outcomes (28-29). In our study, lower PNI was associated with increasing age, lower BMI, higher ECOG-PS, emergency hospitalization, UTI, and a longer hospital stay.

While optimal cutoff values for PNI and SII to predict OS remain elusive, previous research has explored their potential. Mori et al.  utilized ROC curve analysis to find PNI cutoffs, reporting 51 for renal carcinoma and 50 for NSCLC, respectively (30). We found that PNI and SII cutoff values of 42.65 and 1243, respectively, are useful to predict short-term survival.

Our study shows that SII and PNI are important markers for older adults. Patients with low SII and high PNI had better outcomes, while those with low PNI and high SII had worse outcomes. Using both SII and PNI improves prediction.

Study Limitations

It should be noted that this study is subject to several limitations, including its retrospective design, single-center nature, and lack of additional analysis of inflammatory markers, which could have provided further insights into the pathophysiology of the disease.

Conclusions

This study highlights the prognostic value of the PNI, SII, and SII/PNI ratio in predicting short-term survival among older adults. Multivariate COX regression analysis identified percutaneous nephrostomy, lower PNI, and a longer length of hospital stay as independent predictors of poor OS.

Ethics

Ethics Committee Approval: University of Health Sciences Türkiye Medeniyet University Göztepe Training and Research Hospital’s Ethics Committee (decision number: 2023/0823, date: 29.11.2023).
Informed Consent: Retrospective study.

Authorship Contributions

Surgical and Medical Practices: İ.H.Z., M.Ç.Ç., Ö.A., Concept: İ.H.Z., M.Ç.Ç., Ö.A., A.K., A.Y., Design: İ.H.Z., M.Ç.Ç., Data Collection or Processing: İ.H.Z., Ö.A., A.K., A.Y., Analysis or Interpretation: İ.H.Z., Ö.A., A.Y., Literature Search: İ.H.Z., M.Ç.Ç., A.K., A.Y., Writing: İ.H.Z., M.Ç.Ç., A.K.
Conflict of Interest: No conflict of interest was declared by the authors.
Financial Disclosure: The authors declared that this study received no financial support.

References

1
Bongaarts J. United Nations Department of Economic and Social Affairs, Population Division. World Family Planning 2020: Highlights. United Nations Publications; 2020. 46 p. Popul Dev Rev. 2020 Dec;46(4):857-8.
2
Schultzel M, Saltzstein SL, Downs TM, et al. Late age (85 years or older) peak incidence of bladder cancer. J Urol. 2008 Apr;179(4):1302-5.
3
Okamura Y, Sugiura T, Ito T, et al. The optimal cut-off value of the preoperative prognostic nutritional index for the survival differs according to the TNM stage in hepatocellular carcinoma. Surg Today. 2017 Aug;47(8):986-93.
4
Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014 Dec 1;20(23):6212-22.
5
Wang L, Wang C, Wang J, et al. A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2017 Oct;143(10):2077-86.
6
Chovanec M, Cierna Z, Miskovska V, et al. Systemic immune-inflammation index in germ-cell tumours. Br J Cancer. 2018 Mar 20;118(6):831-8.
7
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13.
8
Eredics K, Luef T, Madersbacher S. The future of urology: nonagenarians admitted to a urological ward. World J Urol. 2021 Sep;39(9):3671-6.
9
Pinato DJ, North BV, Sharma R. A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the Prognostic Nutritional Index (PNI). Br J Cancer. 2012 Apr 10;106(8):1439-45.
10
Mohri Y, Inoue Y, Tanaka K, et al. Prognostic Nutritional Index predicts postoperative outcome in colorectal cancer. World J Surg. 2013 Nov;37(11):2688-92.
11
Xuejuan Y. Association between Onodera’s Prognostic Nutritional Index and adverse effects of concurrent chemoradiotherapy for esophageal squamous cell carcinoma. Zhongguo Aizheng Zazhi. 2020 Aug 6;30(7):525-30.
12
Beal EW, Wei L, Ethun CG, et al. Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium. HPB (Oxford). 2016 Nov;18(11):950-7.
13
Diakos CI, Charles KA, McMillan DC, et al. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014 Oct;15(11):e493-503.
14
Lach K, Peterson SJ. Nutrition support for critically ill patients with cancer. Nutr Clin Pract. 2017 Oct;32(5):578-86.
15
Castillo-Martínez L, Castro-Eguiluz D, Copca-Mendoza ET, et al. Nutritional assessment tools for the identification of malnutrition and nutritional risk associated with cancer treatment. Rev Invest Clin. 2018;70(3):121-5.
16
Colotta F, Allavena P, Sica A, et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009 Jul;30(7):1073-81.
17
Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010 Mar 19;140(6):883-99.
18
Hung HY, Chen JS, Yeh CY, et al. Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy. Int J Colorectal Dis. 2011 Aug;26(8):1059-65.
19
Kusumanto YH, Dam WA, Hospers GA, et al. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis. 2003;6(4):283-7.
20
Fondevila C, Metges JP, Fuster J, et al. p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer. 2004 Jan 12;90(1):206-15.
21
Cools-Lartigue J, Spicer J, McDonald B, et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest. 2013 Jul 1;123(8):3446-58.
22
Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000 Mar;182(3):311-22.
23
Mohd Nor Z. Parasitic infection among foreign workers: serological findings. J Health Transl Med. 2002 Jun 24;7(1):70-6.
24
Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004 Aug;21(2):137-48.
25
Zhao H, Wu L, Yan G, et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther. 2021 Jul 12;6(1):263.
26
Onodera T, Goseki N, Kosaki G. [Prognostic Nutritional Index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi. 1984 Sep;85(9):1001-5. Japanese. PMID: 6438478.
27
Kobayashi H, Shiota M, Sato N, et al. Differential prognostic impact of complete blood count-related parameters by prior use of novel androgen receptor pathway inhibitors in docetaxel-treated castration-resistant prostate cancer patients. Anticancer Drugs. 2022 Jan 1;33(1).
28
Okamura Y, Sugiura T, Ito T, et al. The optimal cut-off value of the preoperative prognostic nutritional index for the survival differs according to the TNM stage in hepatocellular carcinoma. Surg Today. 2017 Aug;47(8):986-93.
29
Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest. 2003 Aug;32(3):201-15.
30
Mori S, Usami N, Fukumoto K, et al. The significance of the prognostic nutritional index in patients with completely resected non-small cell lung cancer. PLoS One. 2015 Sep 10;10(9):e0136897.